About the BCIS Public Reports

About the BCIS Public Reports

The Data

The British Cardiovascular Intervention Society was founded in 1988 and represents cardiologists and allied health care professionals with an interest in interventional cardiovascular procedures in all countries of the United Kingdom. The Society promotes education, training and research in cardiovascular intervention and develops and upholds clinical and professional standards to try to ensure that all patients being treated by PCI get the best possible care.  We have therefore collected data about the way in which PCI is performed, and outcomes for patients following PCI, for many years.  The data are publicly available on the Society’s web site and have focused on the performance of individual PCI centres. In recent years BCIS has collaborated with the National Institute of Cardiovascular Outcomes Research (NICOR) to collect and analyse these data.

While the main focus has been on the practice of PCI in different hospitals, in recent years we have also presented analyses of the practice of individual PCI consultant operators.  In reading these analyses it is important to understand how they were generated so that their strengths and limitations can be recognised and the information seen in context.

These data have been provided by each centre and their PCI consultant operators.  It is not possible for BCIS or NICOR to validate these data; their accuracy, therefore, rests with the PCI operators and the data collection personnel in the hospital where the PCI was performed.

For each PCI procedure over 100 data items are recorded.  These include:

a)  Information about the patient such as their age, sex and other conditions that they might be suffering from such as diabetes and hypertension.

b)  The reason a patient needs to be treated by PCI.  For example this might be for symptoms of stable angina or because they have presented to a hospital with sudden onset of chest pain due to a heart attack.

c)  The way the PCI was performed, including the techniques employed and the equipment, stents and medications used.

d)  How the patient got on after the PCI and whether there were any adverse events before they were discharged home.

 

list of abbreviations

List of abbreviations
ACS Acute Coronary Syndrome
BCIS British Cardiovascular Intervention Society
CABG Coronary Artery Bypass Grafting
CHD Coronary Heart Disease
ECG Electrocardiogram
MACCE Major Adverse and Cerebrovascular Event
NSTEMI Non ST elevation Myocardial Infarction
PCI Percutaneous Coronary Intervention
STEMI ST elevation Myocardial Infarction
UA Unstable Angina

 

Data Preparation

All PCI procedures performed over a three year period are included in the analysis of numbers, case mix and outcomes (a rolling three year program). For analyses of delays to treatment (STEMI and NSTEMI), radial rates and interhospital transfer rates, only the most recent year’s data are included to ensure the results are as contemporaneous as possible

Clearly only data sent to NICOR can be analyzed. Almost all UK NHS hospitals have uploaded data, and some (but not all) private hospitals.

To assess survival after PCI, the Office of National Statistics provides us with independently assessed life status, by linkage using the NHS number. This analysis is therefore limited to England and Wales. The data are presented as 30 day survival. Patients who present with out of hospital cardiac arrest and require mechanical ventilation prior to PCI are excluded from the survival analyses, but there are no other exclusions (see section ‘split by syndrome’ for an explanation).

Further details are given under ‘Risk Adjusted Outcomes’.

 

which doctors are included

The aim is to include all consultant PCI operators in the UK who performed PCI at any time during the 3 year period

 

The Outcomes

Survival to 30 days after PCI is reported, using life status data provided by the Office of National Statistics. Factors that determine survival after PCI are often not related to the treatments given and procedures performed, but are influenced by the patient’s general state of health and the condition with which they present. For example some patients admitted with a heart attack may die because of extensive damage to the heart and in spite of excellent care including PCI. Most heart attacks are associated with a mortality of about 5%. If a patient presents with a very big heart attack and is in a state of ‘cardiogenic shock’, then in spite of excellent care and a high quality PCI procedure there is about a 50% risk of death (see below)

Nevertheless outcome will also depend on the quality of care given and the timeliness of treatment. For this reason the analysis attempts to account for the differences in how sick patients are when they present, so that what remains of the variation in outcomes might be explained by the care received.

 

TOTAL NUMBER OF PCI PROCEDURES

The data are shown both for each operator and also for each PCI hospital. A skilled interventional cardiologist requires a combination of good clinical judgment and technical ability. Skills can only be maintained by performing a procedure regularly. However, there is no definite cut off below which an operator’s ability to perform high quality PCI will be reduced. BCIS recommends a minimum of 75 PCI procedures in a year (but encourages activity of over 150 procedures a year).

The figures presented here are for the consultant responsible for the PCI procedure, but under certain circumstances a lower volume operator may work with a high volume colleague (a ‘buddy’ or ‘mentor’), and that information is not captured in the data presented.

There are several possible reasons why operators maybe recorded with low procedural volumes. It may genuinely reflect their practice. They may have only been appointed as a consultant part way through the year in question (and so only a subset of their cases will be included). They may have suspended their work due to pregnancy, or by taking a sabbatical. In some cases an operator may have retired part way through the data collection period. There may be an error with data submitted, with missing procedures, or missing consultant GMC numbers associated with procedures.

If an operator has worked on multiple sites, then all data from those sites will be ascribed to that one operator. However some private hospitals have not submitted data electronically to NICOR, and these cases will not be included.

 

NUMBER OF PROCEDURES PERFORMED – SPLIT BY CLINICAL PRESENTATION OF PATIENT

 

Patients need PCI for a variety of different reasons called ‘syndromes’ and these are called the ‘Indications for PCI’. The indications for PCI in each operator’s practice are shown. Below is an explanation of each of these indications.

Stable

Stable angina occurs when a coronary artery becomes progressively narrowed and blood supply to the heart muscle becomes restricted. People usually experience a tight constricting feeling across the chest which may be associated with breathlessness. It is brought on by physical exertion or stress. Patients with stable angina will have been admitted from home for a planned procedure and usually return home the same day or the following day.

Primary PCI (for ST Elevation Myocardial Infarction or STEMI)

Patients presenting with a complete blockage causing ST elevation on the ECG need immediate treatment. If the blockage persists the region of the heart muscle supplied by that artery will progressively die (myocardial necrosis). In the past patients were treated with a drug that dissolved the occlusive clot (thrombolysis), but now the majority are treated by PCI. This emergency treatment is called Primary PCI, and the number of these cases by each consultant (or hospital) is shown (in these data we have also included ‘facilitated PCI’ – where primary PCI is immediately preceded by treatment with certain other medications).

ACS (Non STEMI)

All other acute coronary syndromes (unstable angina and NSTEMI) are usually caused by a partial or intermittent blocked of the coronary artery and do not usually need to be treated immediately. Recommendations are that they are treated during the initial hospital presentation, preferably within 72 hours. These have been grouped together in this category, and labelled ‘ACS (non STEMI)’.

Shock (Patients in cardiogenic shock before the start of the PCI procedure)

In some patients, the damage caused to the heart muscle by a heart attack is so extensive that the pumping function of the heart is profoundly compromised. If the amount of blood pumped around the patient’s body falls too low, it may be insufficient to sustain the normal function of vital organs, and they begin to shut down (for example kidneys, brain and the liver). When this happens a patient is described as being in ‘cardiogenic shock’. The chances of a patient surviving this critical condition are low, even when the best possible care is provided by the cardiac team. Approximately a third to a half of all such patients will succumb. An operator who works in a hospital that sees a relatively large number of such patients will have a higher mortality irrespective of how skilled the teams are in treating such patients. These factors need to be taken into account when interpreting outcome data. The risk adjustment models attempt to correct for these differences, but all such mathematical methods have limitations (see below)

Ventilated Pre op (patients who have sustained out of hospital cardiac arrest)

Another group of patients whose mortality is high, are those whose hearts stop before they can be brought to hospital. They are said to have suffered an ‘out of hospital cardiac arrest’. While such patients often die before reaching hospital, some can be resuscitated by trained bystanders or paramedics. In this case they are usually brought into hospital by ambulance unconscious and attached to a machine to help them breathe (a ventilator). This group are described as ‘Ventilated Pre-Op’. Even if they are successfully brought to hospital the chance of survival remains poor at about 50%. It is also very difficult to predict survival at the time they arrive. For example it is not possible to know if they have already sustained irreversible brain damage (which is the organ most susceptible to damage at the time of cardiac arrest). If this is the case then even after a successful PCI to treat their heart attack, they may never regain consciousness. These cases are listed in the chart, but as there are no mathematical models yet developed to predict outcomes they have not been included in the assessment of risk adjusted outcome.

Other

There are a few other less common reasons for performing PCI which are grouped here.

 

RADIAL ACCESS RATES

To perform PCI, a tube (catheter) needs to be inserted into the patient’s arterial system (see ‘The PCI procedure’). This can be inserted into the artery at the top of the leg (called the femoral artery), or in the wrist (called the radial artery). During the early development of PCI, before full miniaturisation of equipment, large bore tubes had to be used, and so could only be inserted into a large artery (such as the femoral). Through advances in engineering, equipment has become ever smaller, and is now thin enough to be inserted into the smaller, radial artery.

There are several advantages to using the radial artery for access. For example, unlike the femoral artery it does not have other critical structures close by that could be damaged (the femoral artery on the other hand is surrounded by the femoral vein and nerve). It is easier to compress the radial artery to stop bleeding after the tubes are removed, and if any bleeding does occur it is more obvious and so can be corrected more quickly. Furthermore the use of the radial route enables quicker mobilisation after the procedure.

Complications are lower if it is possible to use the radial rather than the femoral route, and radial access results in better long term outcomes and lower mortality. Nevertheless, the radial route is technically more challenging especially if the operator’s previous training and experience has been limited to transfemoral access.

In the public reports we give radial versus femoral access rates for all operators and PCI hospitals. However it is not possible to treat all patients using a radial approach. Some patient’s radial arteries are still too small, and some PCI techniques still require large bore equipment that cannot fit into a an average radial artery. As a result operators who attempt to use a radial route in all appropriate patients will not have 100% radial rates, but rather rates that are likely to be between about 80% and 95%.

 

DOOR TO BALLOON TIMES

If a patient develops an ST Elevation myocardial infarction (STEMI) and is to be treated by primary PCI, then speed is of the essence. A STEMI occurs when a blood vessel supplying the heart muscle blocks completely. In the absence of oxygen and nutrients this part of the heart muscle starts to die. The longer the vessel is blocked, the more heart muscle will die, and so this blockage must be opened as quickly as possible.

The ‘Door to Balloon’ time is a measure of how long it takes a PCI centre to treat such patients. It measures the delay between the arrival of a patient at the hospital, and the re-opening of the blocked artery using PCI. An audit standard is for this to be less than 90 minutes, aiming for less than 60 minutes in higher risk cases. The data are therefore presented as the percentage of patients who were treated within 90 minutes of arrival.

 

interhospital transfer proportion for nstemi

Breakdown by of route of admission

Patients experience longer delays to treatment if the first hospital to which they are admitted does not have the capability to perform PCI. It is therefore best for patients with symptoms of a possible heart attack to be taken directly to a hospital that can perform this treatment.  Higher ‘direct admission’ to a PCI centre reduces delays to treatment and reduces overall time the patient needs to spend in hospital.

 

DELAYS TO TREATMENT FOR NSTEMI

NSTEMI

Data completeness and analysis

Most patient who present with an NSTEMI, need urgent, but not emergency treatment. While delays are not associated with increased mortality, they are associated with an increased rate of heart attacks while waiting for treatment, and also with prolonged hospital stay.   National and international guidelines suggest that treatment should occur within 72 hours of admission.

To analyse these data we need to know about the patient’s journey through the hospital system. It is particularly important to know when they were first admitted (whether it be to a referring hospital or the PCI centre itself).

This section starts with an analysis of the completeness of the data. Only if the data are sufficiently complete for a meaningful analysis will that analysis be performed.  Hospitals whose data are inadequate are encouraged to make more efforts in data collection.

 

PREDICTED AND ACTUAL SURVIVAL

PERCUTANEOUS CORONARY INTERVENTION (PCI) INDIVIDUAL OUTCOMES DATA

DATA COLLECTION FOR PCI: HOW IT WORKS

DATA COLLECTION FOR PCI: HOW IT WORKS

Section detailing the mechanisms in place for collection of PCI data.

The original BCIS-CCAD dataset for PCI was introduced in 2002 and has since been updated on several occasions.  Details are on the ‘BCIS-CCAD datasets and history’ page. There are several ways in which units can collect these data.

 

BASIC SET-UP

Data are entered via the NCAP section of the NICOR web site.  There are 2 options:

1.  A local database can be used to for data entry.  This database will need to create an export file of the specified csv format, and this can then by uploaded to the NICOR website.

2.  Direct data entry.  Log in to the NCAP section of the NICOR web site, log into the PCI section and enter procedure specific data into the web forms provided

 

1. DIRECT DATA ENTRY

2. DATA ENTRY VIA DEDICATED DATABASE PROGRAM:

2.1 BCIS PCI DATABASE

I have designed a PCI database program using Microsoft Access. This is available for free download on the ‘Current PCI database’ page. In addition to providing procedure reports and a variety of analyses, it creates a commas separated values (csv) file in the format required for upload to NICOR.

2.2 COMMERCIAL DATABASES

There are a number of commercially available database systems. These also all work by extracting the required data to create a csv file in the appropriate format for upload to NICOR.

3. WEB BROWSER

Peter Ludman 2020

BCIS Peer Review Service

BCIS Peer Review Service

BCIS are pleased to provide its Peer Review Service service, designed to assist researchers and available without charge to all BCIS members.

OUR AIM:

To help BCIS members, who have developed a research proposal, to further refine this through constructive review and feedback – thus preparing researchers to navigate ‘hurdles’ such ethics committees, funding applications etc. and progress to active projects with a high likelihood of successful completion and reporting.

WHO CAN APPLY?:

This service will be available to any current BCIS member, irrespective of their current post, or previous research experience.

WHAT WE CAN DO FOR YOU:

The peer-review service is able to provide the following:

Principal Review

Review, by 2-3 consultant-level clinicians or senior academics, of the research proposal. Reviewers will usually be drawn from the BCIS membership, although for specific issues where other expertise is needed, external review may sometimes be sought.

We aim to provide a rapid turnaround, with these responses usually fed back to the submitting member within 4 weeks.

Additional Specialist Review

Applicants may request additional specialist review in the following domain:

i) Specialist statistical review – in specific cases where complex statistical methods are necessary as part of the protocol and where expertise in the relevant area is not available within BCIS

The BCIS research group will seek to commission these services for selected projects that are at an advanced stage of development and that are deemed, from the main review, to be close to finalisation.

Applicants not selected for immediate specialist review may re-apply as their project matures, for example after resolution of key issues raised in the principal review.

KEY GUIDING PRINCIPLES UNDERLYING THE BCIS PEER REVIEW SERVICE:

CONFIDENTIALITY – including the following working rules:

i) Proposals will only be seen by, and circulated amongst, the selected reviewers and the peer-review scheme coordinators

ii) Feedback will be provided directly via the coordinators to the submitting researcher only

iii) The option to choose anonymised (i.e. blind) review, if the submitting member prefers

KEY GUIDING PRINCIPLES UNDERLYING THE BCIS PEER REVIEW SERVICE:
CONSTRUCTIVE – hence no reason for members who are considering making a submission for peer review to feel intimidated about seeking BCIS input.

COLLEGIATE – ownership of the idea and the project will remain entirely with the submitting researcher.

WHAT TO DO NEXT

1) Please download and read the two “Getting Started” documents below.

Getting Started One.

Getting Started Two.

– Getting Started 1 is a description of the anticipated format and content of research proposals to be submitted to BCIS for peer review.

– Getting Started 2 is a checklist of further specific details that we will need, in order to provide the most useful research feedback possible to users of the service.

2) Once you are ready to submit for peer review, please email the research protocol, together with the completed checklist, to the email address below:
bcis@millbrookconferences.co.uk

BCIS Research and Development Group, January 2015

CURRENT PCI DATABASE

CURRENT PCI DATABASE

A database designed to capture details about percutaneous coronary intervention procedures.

This PCI Database is designed to capture details about percutaneous coronary interventional procedures. Procedure reports and GP letters can be created, the data can be analysed within the database, or exported for analysis. This database is designed to collect the dataset agreed by the British Cardiovascular Intervention Society (BCIS) / National Institute for Cardiovascular Outcomes Research (NICOR). It can create the comma separated values (csv) file required for upload data to the NICOR servers. I have written the database in Access 2002.  Version 19.0 is the latest and incorporates library updates (as 2021)

 

Jan 2021

Version 19.0

The latest version of the database below is version 19.0.  I suggest that anyone who wants to start from scratch using this database starts with version 19.0  The three files required are available for download here:

  1. PCI Database Version 19.0
  2. Mousehook dll
  3. Release Notes for version 18.x

 

 

For earlier versions of the database:

May 2019 Menu Options update

To incorporate the new library options introduced in May 2019, 4 tables in the database need to be replaced with new versions.  Instructions to do this are in this file.

The file containing those tables can be downloaded at this link (it will need to be unzipped once downloaded) BCIS database updated tables

This database is not locked so the code can be explored and modified if necessary (see Release Notes ‘getting inside the database’). You can ask your IT department to set up a link between this database and your local hospital Patient Administration System, so that patient demographics, NHS numbers etc. do not have to be entered manually. A link to the lab results server is also very helpful.

The database is designed so that most of the data is entered during and at the end of a PCI procedure, and a procedure report can be printed for the patient notes at that stage. A final set of data is entered after patient discharge.

The data can be analysed using the queries I have written, and in addition the full dataset (excluding sub-tables) can be exported to Microsoft Excel to be analysed elsewhere. In addition once the data are uploaded to NICOR (via the NCAP web site), there is a suite of tools to analyse the live data, with National comparisons available.

 

By Peter F Ludman, BCIS Audit Lead

RELATED RESOURCES

BCIS PCI DATA COLLECTION AND VALIDATION: HOW TO AND GUIDANCE DOCUMENTS

BCIS PCI DATA COLLECTION AND VALIDATION: HOW TO AND GUIDANCE DOCUMENTS

Downloadable guidance documents regarding the upload of PCI data to NICOR and analysis to produce the Clinical Outcomes Publication validation and final report

RELATED RESOURCES

BCIS PCI DATASETS – UPDATES HISTORY

BCIS PCI DATASETS – UPDATES HISTORY

CURRENT DATASET AND VERSION

 

16th May 2019

To all database PCI operators, database contacts and database software providers

Dear colleagues,

I have updated the PCI dataset libraries, to try to capture more recent changes to our armamentarium. These are ONLY library updates, and affect only 4 libraries.  There is no change to the overall structure of the database.

We would hope that most centres will be able to update their library options rapidly, but would hope that all will have done this by the next 6 months at the latest.

The dataset is now named: ‘PCI_Dataset_Standard 5_6_5 version 1-05-2019’ and can be downloaded as an excel file from:

 

The changes are summarised below:

5.09       ECG ischaemia

The following have been added:

  1. CT fractional flow reserve
  2. QFR (Quantitative Flow Ratio or equivalent angiographic analysis of flow)

3.17 Drug eluting stents

The following have been added:

  1. Papyrus (Biotronik)
  2. Graft master (Abbott)
  3. Over and Under (ITGI)
  4. BeGraft (Bentley)
  5. Magmaris (Biotronik)
  6. EluNIR (Cordis Cardinal Health)
  7. Xience Alpine (Abbott)
  8. Xience Sierra (Abbott)
  9. Supraflex (SMT)
  10. Supraflex Cruz (SMT)
  11. Supralimus (SMT)

3.19 Diagnostic device(s) used during procedure

  1. Pressure wire

Will now be used for any device that assesses a coronary stenosis and requires hyperaemia to be induced. It has been re-named:

  1. Pressure wire (or any other HYPERAEMIC based index of coronary stenosis)

The following have been added:

  1. iFR, RFR, dPR (or any other NON HYPERAEMIC index of coronary stenosis)
  2. NIRS (Near infra-red spectroscopy)

3.20 Procedural device:

  1. Rotational atherectomy

Will now be used for the legacy device and so be renamed

  1. Rotational atherectomy (Rotablator legacy device)
  2. Finecross

Will now be used for both Finecross and ANY other microcather and so has been renamed:

  1. Finecross (or any other microcatheter not in list)

The following have been added:

  1. Drug eluting balloon
  2. Shockwave balloon
  3. Coronary sinus occlusion device – PICSO (Miracor)
  4. Rotational atherectomy (Rotapro device)

Please note  that where options have been re-named, the previous and new names will both be accepted

There is no change to the underlying structure of the dataset.

The only thing you need to do is to update your library drop down lists.

4th August 2016

Dataset Version 5.6.5 (August 2016)

Sent to all commercial DB vendors and all Database audit contact and PCI database clinical leads:

I have updated the BCIS PCI dataset. The ‘change history’ tab in the spreadsheet gives the details. They are as follows:
1. A text clarification
2. Clarification of an endpoint definition
3. Minor additions to three of the libraries as:

Library update: 3.17 Drug eluting stent – Addition 46. Orsiro (Biotronik)

Library update: 3.21 Athero-thrombus removal device(s) used – Addition: 13. QXT extraction catheter

Library update: 5.10 Drug therapy PreOp – Addition: 10. Cangrelor

There is no change to the underlying structure of the dataset.

The only thing you need to do is to update your library drop down lists.


30th October 2014

Sent to all All commercial DB vendors and All Database audit contacts

Dataset Version 5.6.2 To be collected from 1st December 2014

Addition to the library of Drug Eluting Stent names only. No change to the database structure.


29th October 2013
Sent to: All commercial DB vendors, All UK PCI operators, All Database audit contacts

Dataset version 5.6.1 To be collected from 1st January 2014

I am always reluctant to change our dataset, but unfortunately there are compelling reasons to make some small changes. There are 11 additional fields (6.01 to 6.11) and additional options to an existing field.

Eleven additional fields:
6.01: PCI indication for stent thrombosis. It has previously been impossible to identify these cases as they could fall under several options available in the ‘Indication for PCI’ field. This new field will allow us to track this particular indication for PCI for the first time.

6.02: As we move towards international standardisation of definitions, we felt it important to have uniform reporting of bleeding complications. This field aligns us to the Bleeding Academic Research Consortium (BARC) definitions.

6.03 to 6.11: Out Of Hospital Cardiac Arrest. We have only been able to infer this specific patient presentation by using the field ‘need for pre-procedural ventilation’. As out of hospital arrest carries its own very specific high risk features we felt it critical to try to capture some key features of patients presenting in this way for PCI. I hope that the data items selected provide the correct balance between essential detail without too burdensome data entry.

Update to existing fields:
3.24 Circulatory support. New LV support device potion have been added to include: Impella, Lucas device, Autopulse and ECMO

What you need to do
1. The commercial suppliers of PCI databases are all being informed of these modifications so that their systems can be upgraded to remain compliant with the BCIS – NICOR audit collection. I recommend you contact then to make sure changes can be effected in time.

2. The Lotus Notes database will be updated in the near future.

3. If you are using my PCI database (in access), then I will shortly be providing a method to allow you to update your database to a newer version that will incorporate all these changes

Best wishes

Peter Ludman
BCIS audit lead


3 September 2013
Sent to all BCIS members and database contacts

Diagnostic Interventional Procedures
The use of FFR, IVUS and OCT (and OFDI etc) when no PCI ensues will be described as an ‘Interventional Diagnostic Procedure’.

An Interventional Diagnostic Procedure is therefore defined as invasive coronary angiography with the use of adjunctive invasive diagnostic equipment such that a coronary device approaches, probes or crosses one or more coronary lesions (including – but not limited to – a pressure wire, intravascular ultrasound and swept laser imaging), before the intention to treat by mechanical revascularisation has been decided. Interventional diagnostic cases should be performed by interventional cardiologists in intervention capable centres.

The definition of a PCI will remain unchanged as:
“A percutaneous coronary intervention (PCI) is deemed to have taken place if any coronary device approaches, probes or crosses one or more coronary lesions, with the intention of performing a coronary intervention. Usually this device will be a guide wire. The only exception to this will be patients who have an adverse cardiac event (during an attempted PCI) that necessitates procedure termination prior to the introduction of a coronary device. This rare type of case will also be defined as a PCI and therefore this will classify as a complication.”

BCIS will plan to report operator’s total numbers of ‘PCI procedures’ and, separately, total numbers of ‘Interventional Diagnostic Procedures’

In order to do this all ‘Interventional Diagnostic procedures’ should now be entered into the BCIS database. To distinguish these from PCI procedures, the following rules need to be applied:

For an ‘Interventional Diagnostic Procedure’:
Total number of lesions attempted (field 3.11) must = 0
and Total number of vessels attempted (field 3.10) must =0
and ‘Diagnostic device(s) used during procedure (field 3.19) should include one of the interventional diagnostic procedures described
Vessels attempted (field 3.09) should be left empty
(Any adverse in-hospital outcomes should be recorded in the same way as for a PCI procedure)

It is suggested that recording all ‘Interventional Diagnostic Procedures’ should start from Jan 2014, but those wishing to add data retrospectively can do so, and it may be possible to include this in the 2013 data reports to be produced in 2014.
Peter Ludman


April 2013
Sent to: All commercial DB vendors, All BCIS members, All Database audit contacts

Dear all

Dataset version 5.5.6 to 5.5.7: To be applied by 1st June 2013
No structural change to the database.
The only changes are to update of some of the menu items in the volatile fields, and some clarification of descriptors.

1. Volatile fields
The following additions have been made to the list:
3.17 Drug based stents

31 Synergy (Boston Scientific)
32 Promus premier (Boston Scientific)
33 Biofreedom (Biosensors)
34 Combo (Orbus)
35 Mguard (InspireMD)
36 Xience Pro (Abbott)
37 Absorb BVS (Abbott)

2. Dataset clarification
Minor changes to clarify the meaning of items:
5.09 ECG Ischaemia. Option 3 ‘on perfusion scan’. This should also be selected for other stress imaging such as stress echo and stress cardiac magnetic resonance imaging.
3.19 Diagnostic device(s) used during procedure. Option 6 relabelled ‘OCT (Optical Coherence Tomography) or similar’. This should be selected for all similar laser swept intracoronary imaging techniques such as optical frequency domain imaging (OFDI).

Attached files:
1. A full history of the dataset changes are documented (Dataset version history)
2. A complete spreadsheet of the new version 5.5.7
(The csv file specification is unchanged)
All these will also be available on the BCIS web site

What you need to do
1. The commercial vendors of databases are all being informed of these modifications.

2. The Lotus Notes database will be updated to include these shortly.

3. If you are using my PCI database, then these changes can be added to the lists by going to the ‘default settings / field lists / database admin’ button on the main switchboard, and then selecting each list to be update in turn and typing in the additions.

Best wishes

Peter Ludman
BCIS Audit Lead
peter.ludman@uhb.nhs.uk


October 2012
Import system and rules for BCIS-CCAD 2012 version

The logical and internal validation rules used by NICOR to check for data consistency during all data uploads can be found here.

Peter Ludman
BCIS Audit Lead
peter.ludman@uhb.nhs.uk


Risk Adjusted Funnel Plots and Delays Report

December 2008

The risk adjusted outcome cummulative funnel plot generator for PCI is now ready to be used. The report works in the same way as the generation of aggregate data reports, and the time delays reports generator. Via the Lotus Notes program in BCIS section, look under the list of reports on the left of the page. Click on ‘ Funnel Plot’. Work your way through the steps, which represent a series of choices regarding the variables and parameters you would like to use to analyse your data .

The report will generate an analysis in the form of a password protected excel spreadsheet. The predicted and observed MACCE are listed for each PCI procedure using your reported CCAD data and the NQWIP model. A cummulative funnel plot is generated with 2 and 3 sigma lines. You will find an explanation of this plot in the last few slides (number 156 to 177) of my BCIS audit presentation of 2007 data at BCIS Audit Returns 2007.

The latest version of the delays report generator for PCI is now ready to be used. The report works in the same way as the generation of aggregate data reports. Via the Lotus Notes program in BCIS section, look under the list of reports on the left of the page. Click on ‘Delay reports v.6’ This will bring up the following dialogue (please see attachment for dialogue).

Work your way through the 7 steps, which represent a series of choices regarding the variables and parameters you would like to use to analyse your data.

The report will generate an analysis in the form of a password protected excel spreadsheet. The worksheets include a measure of your data completeness for the key fields, and explanation of how each field is calculated, and overall analysis of various time intervals in the treatment of patients being treated for acute coronary syndromes. The report will aslo create statistical process control charts allowing you to see (for example) each individual door to balloon time delay for each patient treated for STEMI. These charts can be split to look at night versus day time delays.

I hope you find this is helpful. If you spot any errors in our programming please do not hesitate to contact me.

Peter Ludman
BCIS Audit Lead

RELATED RESOURCES

BCIS TAVI DATASETS – UPDATES AND HISTORY

BCIS TAVI DATASETS – UPDATES AND HISTORY

THE UK TAVI DATASET (VERSION 4)

The dataset group of the UK TAVI Steering group updated the UK TAVI dataset in 2013 from version 3.9 to version 4.

The current dataset (version 4) has been designed to be compatible with the Valve Academic Research Consortium definitions. The new version also includes measures of frailty and hopefully better captures important information that fits with our evolving understanding of this technology and its application.

In the comparison with the old version (3.9) there are three types of fields:

1. Unchanged. Previous ‘CCAD sequence’ number unchanged but a zero has been added to the 3rd decimal place (e.g. 1.01 has become 1.010).

2. Unchanged but for modifications to options. Also keep old CCAD sequence number but with extra decimal place.

3. New fields that have been given a new sequence number and can be identified as having a non zero digit in the 3rd decimal place, e.g. 3.041. Some of these new fields are derivable from previous fields, and some are not.

Many old fields have been deleted and so the overall size of the dataset is more or less unchanged. As before, you will find definitions and explanations to the right of the sheet. Range checks and validation rules for appropriate fields are also included.

There has been an amalgamation of complications so there is no longer a split between events occurring in lab and after lab up to discharge.

The plan is for all units to start to collect this dataset from the 1st January 2013. For those using the web based entry system programmed by CCAD / NICOR, this will be updated at that time. For those using in-house or commercial databases to collect data, we urge you to contact your database programmers as quickly as possible so that your data entry systems can be upgraded in time for the start of data collection with the new dataset.

UK TAVI Dataset version 4 (4.09 20122012)
TAVI CSV File Format and Importing into the database

Peter Ludman
On behalf of the UK TAVI Dataset Group
June 2012

 

ROLLING OUT TAVI IN THE UK

Early clinical results for the technique of transcatheter aortic valve implantation (TAVI) have been encouraging and many interventional cardiology centres are keen to set up a TAVI programme. Although there are several registries outlining clinical results, randomised controlled trials have either not been performed or are currently enrolling. Such trials are important in establishing the role of the new technology but in their absence, commissioners of healthcare need guidance to ensure equal access to treatment.

The Department of Health Heart Team, in collaboration with the NHS Improvement Programme and the clinical networks in England, held a consensus meeting on December 16th 2008 in London. This was well attended. The presentations are available on the Improvement Programme Website.

At this meeting a joint statement from the Society for Cardiothoracic Surgery in Great Britain and Ireland (SCTS) and the British Cardiovascular Intervention Society (BCIS) was released (BCIS SCTS position statement).

Since that time the national societies have been working with the national commissioning group and have produced guidance for commissioners. This has now been released to all regional commissioning groups in England (Guidance Document).

The various stakeholders have set up a Research Development Group that will be meeting in April 2009 to determine how research and audit relating to this new technology can be organised in the UK.

Mark de Belder
President, BCIS
March 23rd 2009

 

TAVI DATASET

Transcatheter Aortic Valve Implantation (TAVI) Dataset UPDATE 28/9/2009

The transcatheter implantation of prosthetic aortic valves is expanding extremely rapidly across the UK. This is a technology in the early stages of evolution, and for which there are currently few data on medium and long term outcomes. It is a technology with enormous potential, and there seems little doubt that it will play an important part in the treatment of aortic stenosis in frail patients unsuitable for conventional surgical aortic valve replacement.

NICE guidance published in June 2008 (IPG 266) supports appropriate use of TAVI, and suggests all procedures should be recorded in a national database.

Several members of the British Cardiovascular Intervention Society and the Society of Cardiothoracic Surgeons have been working together to try to produce an agreed dataset for TAVI.

It is intended that all units implanting transcatheter aortic valves will complete this dataset for each procedure, and that these data will all be gathered using the mechanisms in place at Central Cardiac Audit Database (CCAD).

A web based user interface is being designed by CCAD, that will allow direct entry of these data into the CCAD servers. If units wish to use their own database software, then the option to upload a csv file via the Lotus Notes user interface will also be available.

It is possible to apply to use the UK TAVI dataset for research. For details please see the data sharing agreements below.

TAVI Data Sharing Agreement

TAVI Data Sharing Agreement Application Form